Viemed Healthcare projects significant revenue and EBITDA growth for 2025, with EPS expected to rise by 42.86% in 2025. Read ...

McDonald's is rated HOLD despite growth. Read here for an update on MCD stock's overvaluation, Q4 earnings misses, and target ...

Here is what the fund said: “The largest contributors to returns were Booking Holdings Inc. (NASDAQ:BKNG) and Liberty Formula ... growth of 9% driving Earnings Per Share growth of 16%, a run ...

The latest trading session saw Abbott (ABT) ending at $124.50, denoting a -2% adjustment from its last day's close. The stock's change was more than the S&P 500's daily loss of 3.46%. Meanwhile, the ...

Without a recession, Goldman Sachs now expects the Fed to make three-quarter point interest rate cuts starting in June, ...

The latest Market Talks covering Financial Services. Exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ...

For the second quarter, Equifax targeted adjusted earnings in a range between $1.85 and $1.95 a share on revenue in a range between $1.495 billion and $1.525 billion. For 2025, Equifax continues to ...

Halozyme Therapeutics managed to grow EPS by 7.9% per year, over three years. While that sort of growth rate isn't anything to write home about, it does show the business is growing. One way to ...

While the historical EPS growth rate for Xylem is 15%, investors should actually focus on the projected growth. The company's EPS is expected to grow 9.2% this year, crushing the industry average ...

Stock pickers are generally looking for stocks that will outperform the broader market. And in our experience, buying the right stocks can give your wealth a significant boost. To wit, the RHB Bank ...

Total wireless service revenue growth of 2.0 percent to 2.8 percent. Adjusted EBITDA growth of 2.0 percent to 3.5 percent. Adjusted EPS growth of 0 to 3.0 percent. Cash flow from operations of $35.0 ...